Escolar Documentos
Profissional Documentos
Cultura Documentos
24/04/15 00:02
Regular insulin
From Wikipedia, the free encyclopedia
Regular insulin
Clinical data
AHFS/Drugs.com monograph
MedlinePlus
a682611
US: -only
Legal status
Contents
Routes of
administration
Subcutaneous, intramuscular,
intravenous
Identifiers
1 Medical uses
Chemical data
2 Side effects
3 Society and culture
3.1 Manufacture
3.2 Formulations
4 References
Medical uses
It is used for the long term management of diabetes.[2] Regular insulin is the treatment of choice for the two
diabetic emergencies diabetic ketoacidosis and hyperosmolar hyperglycemic states.[2] It may also be used in
combination with glucose to lower potassium levels in those with hyperkalemia.[2]
Side effects
Side effects may include: low blood sugar levels, skin reactions at the site of injection and low potassium levels
among others.[2]
Pgina 1 de 3
24/04/15 00:02
approval with the U.S. Food and Drug Administration. The Lente series was discontinued by Lilly in 2005.
Prior to the development of synthesized human insulin, patients were dependent on animal insulin which was
more costly, less accessible, and caused infections in some patients.
Humulin is synthesized in a laboratory strain of Escherichia coli bacteria which has been genetically altered
with recombinant DNA to produce biosynthetic human insulin. Humulin R consists of zinc-insulin crystals
dissolved in a clear fluid. The synthesized insulin is then combined with other compounds or types of insulin
which affect its shelf life and absorption. For example, Humulin N is combined with protamine to extend the
time-activity profile of Humulin R for an extended period.
Formulations
It is currently sold by Eli Lilly under different types:
Humulin R (REGULAR human insulin injection [rDNA origin]) is a short-acting insulin that has a
relatively short duration of activity as compared with other insulins.
Humulin R Regular U-500 (Concentrated) insulin human injection, USP (rDNA Origin) is a stronger
concentration (500 units/mL) of Humulin R.
Humulin N (human NPH insulin injection [rDNA origin]) is an intermediate-acting insulin with a slower
onset of action and a longer duration of activity than Humulin R.
Humulin 70/30 (70% human insulin isophane suspension, 30% human insulin injection [rDNA origin]) is
a mixture insulin. It is an intermediate-acting insulin combined with the onset of action of Humulin
Humulin 50/50 (50% human insulin isophane suspension, 50% human insulin injection [rDNA origin]) is
a mixture insulin. It is an intermediate-acting insulin combined with the onset of action of Humulin R.
Humulin is identical in chemical structure to human insulin.
References
1. "insulin regular human (OTC) - Humulin R, Novolin R" (http://reference.medscape.com/drug/humulin-r-novolin-rinsulin-regular-human-999007). Retrieved 1 December 2014.
2. "Insulin Human" (http://www.drugs.com/monograph/insulin-human.html). www.drugs.com. Retrieved 1 December 2014.
Pgina 2 de 3
24/04/15 00:02
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may
apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia is a registered
trademark of the Wikimedia Foundation, Inc., a non-profit organization.
http://en.wikipedia.org/wiki/Regular_insulin
Pgina 3 de 3